Displaying drugs 101 - 125 of 137 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB00100 |
Coagulation Factor IX
9001-28-9 |
46548.2000 C2041H3136N558O641S25 |
|
Coagulants / Thrombotic Agents | For treatment of hemophilia (Christmas disease). |
| DB00086 |
Streptokinase
9002-01-1 |
47286.7000 C2100H3278N566O669S4 |
|
Thrombolytic Agents | For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and ... |
| DB00076 | Digoxin Immune Fab |
47301.7000 C2085H3223N553O672S16 |
|
Digoxin Antidote | For treatment of digitoxin overdose or digitalis glycoside toxicity. |
| DB01270 |
Ranibizumab
347396-82-1 |
48349.6110 C2158H3282N562O681S12 |
|
Ophthalmics / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Inhibitor | For the treatment of patients with macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. |
| DB04895 |
Pegaptanib
222716-86-1 |
50000.0000 |
|
For the treatment of neovascular (wet) age-related macular degeneration. | |
| DB00005 |
Etanercept
185243-69-0 |
51234.9000 C2224H3475N621O698S36 |
|
Antirheumatic Agents / Immunomodulatory Agents | For treatment of severe active rheumatoid arthritis in adults, severe juvenile idiopathic arthritis, ankylosing spondylitis, and severe plaque psor... |
| DB08869 |
Tesamorelin
901758-09-6 |
5135.9 Daltons (base free) C221H366N72O67S • xC2H4O2 where x averages 7.4 acetate counter ions per peptide molecule. |
|
Hormones | Tesamorelin acetate is a synthetic analogue of human hypothalamic Growth Hormone Releasing Factor (hGRF) indicated to induce and maintain a reducti... |
| DB00092 |
Alefacept
222535-22-0 |
51801.1000 C2306H3594N610O694S26 |
|
Immunomodulatory Agents / Immunosuppressive Agents | As an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis |
| DB00070 |
Hyaluronidase
488712-31-8 |
53870.9000 C2455H3775N617O704S21 |
|
Anesthetic Adjuvants / Permeabilizing Agents | For increase of absorption and distribution of other injected drugs and for rehydration. |
| DB00055 |
Drotrecogin alfa
60202-16-6 |
55000.0000 C1786H2779N509O519S29 |
|
Antisepsis Agents | For reduction of mortality in patients with severe sepsis. |
| DB00053 |
Imiglucerase
143003-46-7 |
55597.4000 C2532H3854N672O711S16 |
|
Enzyme Replacement Agents | For the treatment of Gaucher's disease (deficiency in glucocerebrosidase) |
| DB00088 |
Alglucerase
37228-64-1 |
55597.4000 C2532H3854N672O711S16 |
|
Enzyme Replacement Agents | For the treatment of Gaucher's disease (deficiency in glucocerebrosidase) |
| DB01279 |
Galsulfase
552858-79-4 |
56000.0000 C2534H3851N691O719S16 |
|
Enzyme Replacement Agents | For the treatment of adults and children with Mucopolysaccharidosis VI. |
| DB08876 |
Taliglucerase Alfa
37228-64-1 |
56637.9397 g/mol C2580H3918N680O727S17 |
|
Enzyme | For the treatment of adult Type 1 Gaucher disease. |
| DB00004 |
Denileukin diftitox
173146-27-5 |
57647.3000 C2560H4042N678O799S17 |
|
Antineoplastic Agents | For treatment of cutaneous T-cell lymphoma |
| DB00030 |
Insulin recombinant
9004-10-8 |
5795.6000 C257H387N65O76S6 |
|
Hypoglycemic Agents | For treatment of Type I and II diabetes mellitus. |
| DB00071 |
Insulin, porcine
9004-14-2 |
5795.6000 C257H387N65O76S6 |
|
Hypoglycemic Agents | For the treatment of type I and II diabetes mellitus. |
| DB00046 |
Insulin Lispro
133107-64-9 |
5808.0000 C257H387N65O76S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus. To be used in conjunction with an intermediate or long-acting insulin except when used in a con... |
| DB00031 |
Tenecteplase
191588-94-0 |
58951.2000 C2561H3919N747O781S40 |
|
Thrombolytic Agents | For treatment of myocardial infarction and lysis of intracoronary emboli |
| DB00009 |
Alteplase
105857-23-6 |
59042.3000 C2569H3928N746O781S40 |
|
Thrombolytic Agents | For management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli |
| DB00029 |
Anistreplase
81669-57-0 |
59042.3000 C2569H3928N746O781S40 |
|
Thrombolytic Agents | For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction |
| DB00008 |
Peginterferon alfa-2a
198153-51-4 |
60000.0000 |
|
Antineoplastic Agents / Immunomodulatory Agents / Antiviral Agents | For treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma. |
| DB00047 |
Insulin Glargine
160337-95-1 |
6063.0000 C267H408N72O77S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus in patients over 17 years old who require a long-acting (basal) insulin for the control of hyper... |
| DB05259 |
Glatiramer Acetate
147245-92-9 |
623.6505 C25H45N5O13 |
|
Immunosuppressive Agents / Adjuvants, Immunologic | For reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis. |
| DB06692 |
Aprotinin
9087-70-1 |
6511.4390 C284H432N84O79S7 |
|
Antifibrinolytic Agents | For prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the cou... |
Displaying drugs 101 - 125 of 137 in total